Mahapol P. THE PREVALENCE AND ASSOCIATED RISK FACTORS OF REBOUND HYPERTHYROIDISM IN GRAVES’ DISEASE AFTER ANTI-THYROID DRUG DOSE REDUCTION (PARAGON STUDY). J ASEAN Fed Endocr Soc [Internet]. 2023 Nov. 9 [cited 2024 Nov. 23];38(S3):104. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/3539